Literature DB >> 6655040

Serum antibody responses in naturally occurring influenza A virus infection determined by enzyme-linked immunosorbent assay, hemagglutination inhibition, and complement fixation.

H P Madore, R C Reichman, R Dolin.   

Abstract

Serum antibody responses to influenza A virus infection were examined in 388 normal subjects during a trial of chemoprophylaxis in an outbreak of influenza A in 1980-1981 in which both A/H1N1 and A/H3N2 viruses circulated. Paired serum specimens obtained over a 6-week period were tested for antibodies to both A/H1N1 and A/H3N2 viruses by conventional hemagglutination inhibition, complement fixation, and an enzyme-linked immunosorbent assay (ELISA). Antibody responses detected by ELISA were determined by calculation of the area generated between titration curves of paired sera (area method), as well as by a conventional endpoint dilution method (endpoint method). Forty-two significant antibody rises were detected; 42 by ELISA (area method), 33 by ELISA (endpoint method), 32 by hemagglutination inhibition, and 13 by complement fixation. ELISA (area method) detected rises more frequently than either ELISA (endpoint method) (P less than 0.01), hemagglutination inhibition (P less than 0.005), or complement fixation (P less than 0.001). Another sensitive assay, the microneutralization test, detected significantly fewer rises (33, P less than 0.025) than the ELISA (area method). In the 42 subjects with ELISA (area method) rises, corroborating evidence of influenza A infection by other techniques (virus isolation, microneutralization, hemagglutination inhibition, or complement fixation tests) were available for 39 (93%). ELISA (area method) rises were subtype specific in all serum pairs in which other documentation of subtype-specific infection was available (38 of 38). Thus, ELISA (area method) was the single most sensitive assay for detection of serum antibody rises in this setting and possessed a high degree of subtype specificity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6655040      PMCID: PMC272905          DOI: 10.1128/jcm.18.6.1345-1350.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Enzyme-linked immunosorbent assay for detection of antibodies to influenza A and B and parainfluenza type 1 in sera of patients.

Authors:  F R Bishai; R Galli
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

2.  A new micro-neutralization test for antibody determination and typing of parainfluenza and influenza viruses.

Authors:  H Wulff; J Soeken; J D Poland; T D Chin
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

3.  A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.

Authors:  R Dolin; R C Reichman; H P Madore; R Maynard; P N Linton; J Webber-Jones
Journal:  N Engl J Med       Date:  1982-09-02       Impact factor: 91.245

4.  Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses.

Authors:  B R Murphy; M A Phelan; D L Nelson; R Yarchoan; E L Tierney; D W Alling; R M Chanock
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

5.  Sensitivity and specificity of enzyme immunoassay for serodiagnosis of influenza A virus infections.

Authors:  G W Hammond; S J Smith; G R Noble
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

6.  Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines.

Authors:  B R Murphy; E L Tierney; B A Barbour; R H Yolken; D W Alling; H P Holley; R E Mayner; R M Chanock
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

  6 in total
  10 in total

1.  Comparison of complement fixation and hemagglutination inhibition assays for detecting antibody responses following influenza virus vaccination.

Authors:  Harry E Prince; Amy L Leber
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

2.  Immunization of elderly volunteers with the 1988-89 inactivated whole influenza vaccine: assessment of antibody responses by haemagglutination inhibition and single radial haemolysis tests.

Authors:  A M Iorio; T Zei; M Neri; L Campitelli; M R Castrucci; I Donatelli
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

3.  Isotype-specific enzyme immunoassay for influenza antibody with monoclonal antibodies to human immunoglobulins.

Authors:  M W Harmon; D J Phillips; C B Reimer; A P Kendal
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

4.  Immunoglobulin class-specific serological responses to adenovirus in respiratory infections of young adult men.

Authors:  I Julkunen; K Lehtomäki; T Hovi
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

5.  Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.

Authors:  J J Treanor; F K Roth; R F Betts
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

6.  Age-dependent antibody response in mice and humans following oral influenza immunization.

Authors:  R H Waldman; K C Bergmann; J Stone; S Howard; V Chiodo; A Jacknowitz; E R Waldman; R Khakoo
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

7.  Immune response to influenza vaccination in children with renal disease.

Authors:  S L Furth; A M Neu; S A McColley; B Case; M Steinhoff; B Fivush
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

8.  Diagnosis of influenza A virus infections by detection of specific immunoglobulins M, A, and G in serum.

Authors:  T Vikerfors; G Lindegren; M Grandien; J van der Logt
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

9.  Use of recombinant nucleoproteins in enzyme-linked immunosorbent assays for detection of virus-specific immunoglobulin A (IgA) and IgG antibodies in influenza virus A- or B-infected patients.

Authors:  J T Voeten; J Groen; D van Alphen; E C Claas; R de Groot; A D Osterhaus; G F Rimmelzwaan
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

10.  Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings.

Authors:  A R Falsey; J J Treanor; R F Betts; E E Walsh
Journal:  J Am Geriatr Soc       Date:  1992-02       Impact factor: 5.562

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.